Trial intelligence / Profile preview

R-Pdf/Gbb in third degree thermal and electrical burns

NCT00812513Phase 2Unknown

Sponsor
American Scitech International
Start
Jul 2011
Primary completion
Apr 2012
Countries
1
01

Overview

A Phase 2 trial of becaplermin in burn injury, electrical burn, sponsored by American Scitech International. Status: unknown.

02

Drugs

becaplermin
03

Conditions

burn injuryelectrical burn

Beyond the preview

Go deeper on NCT00812513.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00812513.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call